Patent 5773020 Issued on June 30, 1998. Estimated Expiration Date: October 28, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
Erectile dysfunction, particularly impotence, priapism and Peyronie's disease is treated by the transurethral administration of a therapeutically effective agent. The agents are administered to the urethra by means of a penile insert (1) having a rapidly releasing coating (4) containing the agent on its exterior surface or by means of an inserter (27) carrying an agent containing dose of agent (31) which can be displaced into the urethra.
Other References
Althof, S.E., et al., "Why Do So Many People Drop Out From Auto-Injection Therapy for Impotence?", Journal of Sex & Marital Therapy 15(2):121-129 (1989)
Brindley, G.S., "Cavernosal Alpha-Blockade: A New Technique For Investigating And Treating Erectile Impotence", Brit. J. Psychiatry 143:332-337 (1983)
Fabbri, A., et al., "Endorphins in Male Impotence: Evidence for Naltrexone Stimulation of Erectile Activity in Patient Therapy", Psychoneuroendo 14:103-111 (1989)
Fishman, I.J., "Treating Erectile Dysfunction", Drug Therapy 19:102-111 (1989)
Ishii, N., et al., "Intracavernous Injection of Prostaglandin E1 for the Treatment of Erectile Impotency", Journal of Urology 141:323-325 (1989)
Kursh, E.D., et al., "Injection Therapy for Impotence", Urologic Clinics of North America 15(4): 625-629 (1988)
Lal, S.Y., et al., "Apomorphine: Clinical Studies on Erectile Impotence and Yawning", Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 13:329-339 (1989)
Lee, L.M., et al., "Prostaglandin E1 v. Phentolamine/Papaverine for the Treatment of Erectile Impotence: A Double-Blind Comparison" Jour.of Urol. 141:549-550 (1989)
Levine, S.B., et al., "Side Effects of Self-Administration of Intracavernous Papaverine and Phentolamine for the Treatment of Impotence", Journal of Urology 141:54-57 (1989)
Morley, J.E., "Impotence", America Journal of Medicine 80:897-905 (1986)
Owen, J.A., et al., "Topical Nitroglycerin: A Potential Treatment for Impotence", Journal of Urology 141:546-548 (1989)
Rousseau, P., "Impotence in Elderly Men", Postgraduate Medicine 83:212-219 (1988)
Sarosdy, M.F., et al., "A Prospective Double-blind Trial of Intracorporeal Papaverine v. Prostaglandin E1 in the Treatment of Impotence", Journal of Urology 141:551-553 (1989)
Schramek,P., et al., "Dose-Dependent Effect and Side-Effect of Prostaglandin E1 in Erectile Dysfunction", British Journal Clinical Pharmac. 28:567-571 (1989)
Stackl, W., et al., "Intracavernous Injection of Prostaglandin E1 in Impotent Men", Journal of Urology 140:66-68 (1988)
Virag, R., et al., "Intracavernous Injection of Papaverine as a Diagnostic and Therapeutic Method in Erectile Failure", Angiology 35:79-87 (1984)
Waldhauser, M., et al., "Efficiency and Side Effects of Prostaglandin E1 in the Treatment of Erectile Disfunction", Journal of Urology 140:525-527 (1988)
Zorgniotti, A.W., et al., "Auto-Injection of the Corpus Cavernosum with a Vasoactive Drug Combination for Vasculogenic Impotence", Journal of Urology 133:39-41 (1985)
Andersson, K-E., et al., "Relaxation of Isolated Human Corpus Spongiosum Induced by Vasoactive Intestinal Polypeptide, Substance P, Carbachol and Electrical Field Stimulation", World Journal of Urology 1:203-208 (1983)
Andersson, K-E., et al., "Interactions Between Classical Neurotransmitters and Some Neuropeptides in Human Penile Erectile Tissues", Neuronal Messengers in Vascular Function pp. 505-524 (1987)
Andersson, K-E., et al., "Characterization of Immunoreactive Arginine Vasopressin (AVP) in and Effects on Isolated Human Penile Erectile Tissues", J. Urology 137:1278-1282 (1987)
Andersson, K-E, et al., "Immunoreactive Arginine Vasopressin (AVP) and Effects of AVP in the Human Vas Deferens", Journal of Urology 140:1054-1062 (1988)
Church, P., "Impotence, Part 1: Evaluation", HMS Health Letter pp. 4-6 (Sep., 1989)
Church, P., "Impotence, Part 2: Treatment", HMS Health Letter pp. 3-6 (Oct. 1989)
Foveaus, M., et al., "Calcium Channel Blockade and Contractile Responses in the Isolated Human Vas Deferens", Journal of Urology 138:654-658 (1987)
Foveaus, M., et al., "Effects of Some Calcium Channel Blockers on Isolated Human Penile Erectile Tissues", Journal of Urology 138:1267-1272 (1987)
Hedlund, H., et al., "Effects of Prazosin in Patients with Benign Prostatic Obstruction", Journal or Urology 130:275-278 (1983)
Hedlund, H., et al., "Pre-and Postjunctional Adreno-and Muscarinic Receptor Functions in the Isolated Human Corpus Spongiosum Urethrae", J. Auton. Pharmac. 4:241-249 (1984)
Hedlund, H., et al., "Effects of Some Peptides on Isolated Human Penile Erectile Tissue and Cavernous Artery", ACTA Physiol Scand. 124:413-419 (1985)
Hedlund, H., et al., "Contraction and Relaxation Induced by Some Prostanoids in Isolated Human Penile Erectile Tissue and Cavernous Artery", Journal of Urology 136:1245-1250 (1985)
Hedlund, H., et al., "Alpha-Adrenoceptors and Muscarinic Receptors in the Isolated Human Prostate", Journal of Urology 136:1291-1298 (1985)
Hedlund, H., et al., "Effect of Drugs Interacting with Adrenoreceptors and Muscarinic Receptors in the Epididymal and Prostatic Parts of the Human Isolated Vas Deferens", Journal Auton. Pharmacology 5:261-270 (1985)
Hedlund, H., et al., "Characterization of Contraction-Mediating Prostanoid Receptors in Human Penile Erectile Tissues", Journal of Urology 141:182-186 (1989)
Hedlund, H., et al., "Effects of the Tromboxane Receptor Antagonist AH-23848 on Human Isolated Corpus Cavernosum", Int. J. Impotence Res. 1:19-25 (1989)
Krane, R.J., et al., "Impotence", New England Journal of Medicine 321 (24):1648-1659 (1989)
Winslow, R., "Avoiding the Knife: Prostate Patients Get Choice of Treatments that Obviate Surgery", Wall Street Journal vol. CXXII No. 27
Cavallini, G., "Minoxidil Versus Nitroglycerin: A Prospective Double-Blind Controlled Trial in Transcutaneous Erection Facilitation for Organic Impotence", Jour. Urology 146:50-53 (1991)
Mahler, J.C., et al., "Letter", JAMA 259(21):3126 (1988)
Milco, St. M., "Administration intra-uretrale de l'hormone masculine, chez l'homme", Bulletin et Memories De La Societe Roumaine D'Endocrinologie 5:436-437 (1939)
Malloy, T.R., et al., "Pharmacological treatment of impotence", Urologic Clinics of North America 14(2):297-305 see 303-304! (1987)
Klinge, E., et al., "Comparative study of some isolated mammalian smooth muscle effectors of penile erection", Acta Physiol. Scand., vol. 100:354-67 (1977)
Barbanti, G., et al., "Relaxation of isolated corpus cavernosum induced by smooth muscle relaxant drugs", Urol. Res., vol. 16(4):299-302 (1988)
Ahmad, S., "Scleroderma and impotence: Response to nitroglycerin applied to the fingers and penis", South Med. J. 83:1495 (1990)
Talley, J.D., et al., "Transdermal nitrate, penile erection and spousal headache", Ann. Intern. Med. 103:804 (1985)
Hedlund, H., et al., "Comparison of the Responses to Drugs Acting on Adrenorecepors and Muscarinic Receptors in Human Isolated Corpus Cavernosum and Cavernous Artery", J. Auton. Pharmac., 5:81-88 (1985)
Yamamura, K., et al., "High-Performance Liquid Chromatographic Assay for Prostaglandin E1 in Various Ointment Vehicles", J.Chromatography 303:165-172 (1984)
Sundaram, M.B.M., "Seizures After Intraurethral Instillation of Lidocaine," Canad. Med. Assn. J. 137:219-220 (1987)
Negelev, S., "Topical nitroglycerin: a potential treatment for impotence", J. Urol. 143:586 (1990)
Robinette, M.A., et al., "Intracorporal Injection of Papaverine and Phentolamin in the Management of Impotence", Br. J. Urology 58:692-695 (1986)
Heaton, J.P.W., et al., "Topical glyceryltrinitrate causes measurable penilearterial dilation in impotent men.", J. Urology 143:729-731 (1990)
Claes, H., et al., "Transcutaneous Nitroglycerin Therapy in the Treatment of Impotence", Urol. Int., 44:309-312 (1989)
Rudd., et al., The Pharmacological Basis of Therapeutics, Gilman et al. (Eds) 7th Ed., Chap. 32 pp. 784-785 (1985)
Turner, J.E., et al., "Prostaglandin E2 in Tylose Gel for Before Induction of Labor", J. Reprod. Med., 32(11):815-821 (1987)
Andersson, K.E., et al., "Effects of Prostaglandin E2 Applied L Intravesical and Intraurethral Pressures in Women", Eur. Urol., (1978)
Axelsson, K., et al., "Blood Concentration of Lignocaine after Application of 2% Lignocaine Gel in the Urethra", Br. J. Urol., 55(1):64-68 (1983)
Owen, J., et al., "Transcutaneous Nitroglycerine Enhances the Quality of Erections in Impotent Men. Results of a Controlled Trial", J. Urol., 137, 201A, abstract 392 (1987)
Anonymous, "Intracavernous injections for impotence", The Medical Letter, 751:39.95 (1987)
Brindley, G.S., "Cavernosal alpha-blockage: A new technique for investigating an treating erectile impotence", Brit. J. Psychiatr., 143:332-377 (1983)
Brindley, G.S., "Pilot experiments on the actions of drugs injected into the human corpus cavernosum penis", Br. J. Pharmacol, 87:495-500 (1986)
Ishii, N., et al., "Studies on male sexual impotence. Report 18. Therapeutic trial with prostaglandin E1 for organic impotence", 77:954-962 (1986)
Stackl, W., et al., "Intracavernous injection o prostaglandin E1 in impotent men", J. Urol., 140:66-68 (1988)
Virag, R., "Intracavernous injection of papaverine for erectile failure"letter!, Lancet, 2:938 (1982
October 28, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
